560TiP A phase I/IIa study to evaluate the safety and efficacy of CCS1477, a first in clinic inhibitor of p300/CBP, as monotherapy in patients with selected molecular alterations

Subjects

Subjects :

Oncology
medicine.medical_specialty
business.industry
Internal medicine
Phase (matter)
medicine
In patient
Hematology
business

Details

ISSN :

09237534

Volume :

32

Database :

OpenAIRE

Journal :

Annals of Oncology

Accession number :

edsair.doi...........b1db034cfd21046b22dc72e01171c4a7

Full Text :

https://doi.org/10.1016/j.annonc.2021.08.1082